To confirm that NFIX expression in breast cancer is regulated by methylation, we treated normal breast epithelial cell lines and wild-type breast cancer cell lines with the DNA methyltransferase inhibitor AZA at concentrations of 0, 0.5, 1.0, 1.5, 2.0, and 2.5 μM. Here, NFIX is linked to breast carcinoma.